Life sciences patents have not fared well in recent case law, including several cases ruled on by the U.S. Supreme Court, but the Court of Appeals for the Federal Circuit has returned a verdict in the case of Rapid Litigation Management v. Cellzdirect, a case that is seen by some as favorable toward patents that invoke natural law and, by extension, favorable to commercial activity in the life sciences.